Hoag First in World to Enroll Prostate Cancer Patients in Molecular Imaging & Therapy Clinical Trials

NEWPORT BEACH, Calif., April 2, 2024 /PRNewswire/ — Hoag is the first site in the world to enroll patients in two clinical trials for prostate cancer staging and treatment. One trial focuses on molecular imaging and the other on molecular therapy; both are poised to redefine the standard…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks